Pamela D. McGuinness

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

Total Synthesis of the Proposed Structure of Rhodobacter sphaeroides Lipid A Resulting in the Synthesis of New Potent Lipopolysaccharide Antagonists

William J. Christ, Pamela D. McGuinness, Osamu Asano et al. · Journal of the American Chemical Society · 1994 · 87 citations

Lipid Analysis, Bioorganic Chemistry, Altmetric Attention Score +18

A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway

Egil Lien, Jesse C. Chow, Lynn D. Hawkins et al. · Journal of Biological Chemistry · 2001 · 82 citations · Full text

A Novel Class of Endotoxin Receptor Agonists with Simplified Structure, Toll-Like Receptor 4-Dependent Immunostimulatory Action, and Adjuvant Activity

Lynn D. Hawkins, Sally T. Ishizaka, Pamela D. McGuinness et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 62 citations

The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change

Eric J. Nehl, Stacy Heilman, David N. Ku et al. · IEEE Open Journal of Engineering in Medicine and Biology · 2021 · 18 citations · Full text